General Information of Drug Transporter (DT)
DT ID DTD0273 Transporter Info
Gene Name SLC30A4
Transporter Name Zinc transporter 4
Gene ID
7782
UniProt ID
O14863
Post-Translational Modification of This DT
Overview of SLC30A4 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Phosphorylation X-Ubiquitination X: Amino Acid

Phosphorylation

  Serine

          5 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC30A4 [1] , [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

55

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC30A4 Serine 55 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC30A4 [1] , [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

75

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC30A4 Serine 75 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC30A4 [1]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

86

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC30A4 Serine 86 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC30A4 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

384

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC30A4 Serine 384 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC30A4 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

428

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC30A4 Serine 428 has the potential to affect its expression or activity.

  Threonine

          4 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC30A4 [1] , [2]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

68

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC30A4 Threonine 68 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC30A4 [1]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

84

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC30A4 Threonine 84 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC30A4 [5]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

309

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC30A4 Threonine 309 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC30A4 [5]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

319

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC30A4 Threonine 319 has the potential to affect its expression or activity.

Ubiquitination

  Lysine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC30A4 [6]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

106

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC30A4 Lysine 106 has the potential to affect its expression or activity.
References
1 Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1. EMBO J. 2015 Nov 12;34(22):2840-61.
2 Fast Global Phosphoproteome Profiling of Jurkat T Cells by HIFU-TiO2-SCX-LC-MS/MS. Anal Chem. 2017 Sep 5;89(17):8853-8862.
3 Global detection of protein kinase D-dependent phosphorylation events in nocodazole-treated human cells. Mol Cell Proteomics. 2012 May;11(5):160-70.
4 Phosphosignature predicts dasatinib response in non-small cell lung cancer. Mol Cell Proteomics. 2012 Sep;11(9):651-68.
5 Identifying novel targets of oncogenic EGF receptor signaling in lung cancer through global phosphoproteomics. Proteomics. 2015 Jan;15(2-3):340-55.
6 UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol. 2018 Jul;25(7):631-640.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.